<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="P0b002ee18039484f">
<name type="corporate">
 <namePart>United States Government Publishing Office</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
  <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
</role>
 <role>
  <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
  <roleTerm authority="marcrelator" type="code">dst</roleTerm>
</role>
</name>
<name type="corporate">
 <namePart>United States</namePart>
 <namePart>Government Accountability Office</namePart>
 <namePart>General Government Division</namePart>
 <role>
  <roleTerm authority="marcrelator" type="text">author</roleTerm>
  <roleTerm authority="marcrelator" type="code">aut</roleTerm>
</role>
 <description>Government Organization</description>
</name>
<typeOfResource>text</typeOfResource>
<genre authority="marcgt">government publication</genre>
<language>
 <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<extension>
 <collectionCode>GAOREPORTS</collectionCode>
 <category>Legislative Agency Publications</category>
 <waisDatabaseName>gao</waisDatabaseName>
 <branch>legislative</branch>
 <dateIngested>2010-08-12</dateIngested>
</extension>
<originInfo>
 <publisher>U.S. Government Printing Office</publisher>
 <dateIssued encoding="w3cdtf">1997-10-02</dateIssued>
 <issuance>monographic</issuance>
</originInfo>
<physicalDescription>
 <note type="source content type">deposited</note>
 <digitalOrigin>born digital</digitalOrigin>
 <extent>234 p.</extent>
</physicalDescription>
<classification authority="sudocs">GA 1.13:GGD-98-5</classification>
<identifier type="uri">https://www.govinfo.gov/app/details/GAOREPORTS-GGD-98-5</identifier>
<identifier type="local">P0b002ee18039484f</identifier>
<identifier type="former package identifier">f:gg98005</identifier>
<recordInfo>
 <recordContentSource authority="marcorg">DGPO</recordContentSource>
 <recordCreationDate encoding="w3cdtf">2010-08-12</recordCreationDate>
 <recordChangeDate encoding="w3cdtf">2011-03-24</recordChangeDate>
 <recordIdentifier source="DGPO">GAOREPORTS-GGD-98-5</recordIdentifier>
 <recordOrigin>machine generated</recordOrigin>
 <languageOfCataloging>
  <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</languageOfCataloging>
</recordInfo>
<accessCondition type="GPO scope determination">fdlp</accessCondition>
<extension>
 <docClass>REPORT</docClass>
 <accessId>GAOREPORTS-GGD-98-5</accessId>
 <reportNumber>GGD-98-5</reportNumber>
 <subject>Derivative securities</subject>
 <subject>Securities arbitration</subject>
 <subject>Securities regulation</subject>
 <subject>Mortgage-backed securities</subject>
 <subject>Losses</subject>
 <subject>Interagency relations</subject>
 <subject>Banking regulation</subject>
 <subject>Information disclosure</subject>
 <subject>Futures</subject>
 <subject>Securities fraud</subject>
 <type>Chapter Report</type>
 <seriesAbbrev>GGD</seriesAbbrev>
 <law congress="102" isPrivate="false" number="546"></law>
</extension>
<titleInfo>
 <title>OTC Derivatives: Additional Oversight Could Reduce Costly Sales Practice Disputes</title>
</titleInfo>
<abstract>Pursuant to a congressional request, GAO reviewed the sales practices
for over-the-counter (OTC) derivatives, mortgage-backed securities
(MBS), and structured notes, focusing on the: (1) federal sales practice
requirements applicable to these products and the dealers marketing
them; (2) extent of end-user satisfaction with sales practice, product
use, and related disputes and the costs of these disputes; (3) views of
end-users and dealers on the nature of their relationship and
responsibilities; (4) actions dealers and end-users have taken to reduce
the potential for sales practice disputes; and (5) actions regulators
have taken to address sales practice issues.&lt;p/&gt;GAO noted that: (1) the extent to which OTC derivatives are subject to
federal sales practice requirements intended to protect end-users
varies, depending, in part, on whether they are considered to be
securities, futures, or neither; (2) when they are considered to be
securities or futures, their sale is covered by the federal securities
or commodities laws, and they are regulated by the Securities Exchange
Commission (SEC) and the Commodity Futures Trading Commission (CFTC),
respectively; (3) to the extent that these products are not securities
or futures, end-users with sales practice disputes would need to seek
redress against a dealer by asserting primarily state statutory or
common law claims; (4) in contrast to most OTC derivatives, MBS and
structured notes are typically securities and, thereby, subject to the
federal securities laws, except when exempted from specific provisions;
(5) the extent to which sales practice requirements apply to the dealers
marketing OTC derivatives in the United States also varies, depending on
whether the dealer offering them is regulated; (6) when OTC derivatives
are marketed by banks, they are subject to supervisory guidance issued
by federal bank regulators; (7) securities, futures, and insurance
firms, unlike banks, typically market OTC derivatives that they consider
to be neither securities nor futures from affiliates that are not
subject to any direct federal financial regulatory oversight, although
some individual transactions may be subject to such oversight; (8)
although sales practice requirements vary by product and dealer,
according to GAO&apos;s survey, most end-users were generally satisfied with
the sales practices of the dealers with whom they entered transactions;
(9) GAO&apos;s survey also found that relatively few organizations reported
using OTC derivatives; (10) GAO&apos;s review of regulatory and public
records, covering 1993 through 1996, indicated that cases involving
actual or alleged deficiencies in dealer sales practices were limited in
number; (11) however, the dealers and end-users involved in these cases
often experienced significant costs; (12) although generally satisfied
with dealer sales practices, end-users&apos; views on the nature of
counterparty relationships sometimes differed from those of dealers;
(13) in addition, bank regulators have taken certain actions to address
sales practice issues; and (14) although SEC and CFTC do not directly
regulate the affiliates that securities and futures firms use to conduct
their OTC derivatives activities, SEC and CFTC worked with the most
active of these firms to produce one of two sets of voluntary guidance.</abstract>
<location>
 <url displayLabel="HTML rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-GGD-98-5/html/GAOREPORTS-GGD-98-5.htm</url>
 <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/GAOREPORTS-GGD-98-5/pdf/GAOREPORTS-GGD-98-5.pdf</url>
</location>
<identifier type="preferred citation">GAO/GGD-98-5</identifier>
<location>
 <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/GAOREPORTS-GGD-98-5</url>
</location>
<note>Chapter Report</note>
<extension>
 <searchTitle>GAO/GGD-98-5; OTC Derivatives: Additional Oversight Could Reduce Costly Sales Practice Disputes;
            </searchTitle>
</extension>
<subject>
 <topic>Derivative securities</topic>
 <topic>Securities arbitration</topic>
 <topic>Securities regulation</topic>
 <topic>Mortgage-backed securities</topic>
 <topic>Losses</topic>
 <topic>Interagency relations</topic>
 <topic>Banking regulation</topic>
 <topic>Information disclosure</topic>
 <topic>Futures</topic>
 <topic>Securities fraud</topic>
</subject>
<relatedItem type="isReferencedBy">
 <titleInfo>
  <title>United States Public Law 546 (102nd Congress)</title>
</titleInfo>
 <identifier type="public law citation">Public Law 102-546</identifier>
</relatedItem>
</mods>